Basis of Presentation and Summary of Significant Accounting Policies (Details 2) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
|
| Disposable products: | ||
| Functional neurology | $ 1,148,870 | $ 1,290,484 |
| Biologics and drug delivery | 210,930 | 372,965 |
| Total disposable product revenue | 1,359,800 | 1,663,449 |
| Capital equipment | 178,798 | 258,766 |
| Total product revenue | 1,538,598 | 1,922,215 |
| Rental, service and other | 84,768 | 84,857 |
| Total revenue | $ 1,623,366 | $ 2,007,072 |
| X | ||||||||||
- Definition Revenue from biologics and drug delivery. No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue during the period from capital equipment. No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue during the period from disposable products including functional neurology and biologics and durg delivery. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Revenue from functional neurology. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount before allowances and discounts of service revenue classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|